Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1132 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Tibet Pharma designates CEO

Hong Yu has succeeded Taylor Guo, who has left the company for personal reasons. Yu said he would like to thank Taylor Guo for his commitment and dedication

Biota Scientific gets $2.9m grant from NIH

Biota Scientific Management is a wholly subsidiary of an Australia-based anti-infective drug developer, Biota. As part of this 5-year grant funding, the company expects to receive $830,287 in